FMP

FMP

Enter

ANGO - AngioDynamics, Inc.

photo-url-https://images.financialmodelingprep.com/symbol/ANGO.png

AngioDynamics, Inc.

ANGO

NASDAQ

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

9.28 USD

0.51 (5.5%)

Operating Data

Year

2020

2021

2022

2023

2024

2025

2026

2027

2028

2029

Revenue

264.16M

291.01M

316.22M

338.75M

303.91M

315.82M

328.19M

341.05M

354.41M

368.29M

Revenue %

-

10.17

8.66

7.13

-10.28

3.92

3.92

3.92

3.92

Ebitda

-143.74M

-8.9M

11.13M

12.19M

-14.29M

-34.77M

-36.14M

-37.55M

-39.02M

-40.55M

Ebitda %

-54.41

-3.06

3.52

3.6

-4.7

-11.01

-11.01

-11.01

-11.01

Ebit

-167.23M

-35.19M

-18.36M

-20.98M

-42M

-63.94M

-66.44M

-69.04M

-71.75M

-74.56M

Ebit %

-63.31

-12.09

-5.81

-6.19

-13.82

-20.24

-20.24

-20.24

-20.24

Depreciation

23.49M

26.29M

29.5M

33.17M

27.71M

29.16M

30.3M

31.49M

32.72M

34.01M

Depreciation %

8.89

9.03

9.33

9.79

9.12

9.23

9.23

9.23

9.23

EBIT (Operating profit)(Operating income)(Operating earning) = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) EBIT = (1*) (2*) -> operating process (leverage -> interest -> EBT -> tax -> net Income) EBITDA = GROSS MARGIN (REVENUE - COGS) - OPERATING EXPENSES (R&D, RENT) + Depreciation + amortization EBITA = (1*) (2*) (3*) (4*) company's CURRENT operating profitability (i.e., how much profit it makes with its present assets and its operations on the products it produces and sells, as well as providing a proxy for cash flow) -> performance of a company (1*) discounting the effects of interest payments from different forms of financing (by ignoring interest payments), (2*) political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill) (3*) collections of assets (by ignoring depreciation of assets) (4*) different takeover histories (by ignoring amortization often stemming from goodwill)

FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedin
2017-2025 © Financial Modeling Prep